The APS are pleased to announce a unique opportunity of a one-day event which will introduce the scientific principles underlying the use of cells and genetic material as therapeutic products. The design, delivery and manufacture of new medicines will be explored, along with the basis of clinical trials and the regulatory framework that guides their use.

This meeting will gather experts from academia and Pharmaceutical companies and will be ideal for those seeking to understand more about Advanced Therapeutic Products and the journey from initial concept to clinical use.

The event is suitable for those working in, and/or who have an interest in cell and gene therapy. It takes the attendee from the scientific principles of advanced therapeutics to their design, delivery, manufacture, clinical trial and the regulatory process. Experts in the respective areas will present and there will be opportunity for discussion and debate within a dynamic forum.

Postgraduate students working in the area may also wish to attend for whom there is a competitively priced attendance fee.

0900-10.00- REGISTRATION AND ARRIVAL

10.00-10.05-Welcome and Opening Remarks- Rachel Knott (visiting scientist, Robert Gordon University, Aberdeen, Scotland.

RESEARCH AND DEVELOPMENT

10.05-10.40-Design and Delivery methods for cell and gene therapies- Arpan Desai (Astra Zeneca)

10.40-11.15- Advanced Therapies for the treatment of vascular disease-Speaker TBC

11.15-11.30- NETWORKING & COFFEE BREAK

MANUFACTURING OF ADVANCED THERAPEUTICS

11.30-12.30- Short presentations to set the scene followed by panel discussion-Frank Thielmann (Takeda Pharmaceuticals). & Zhara Rattray (Research Fellow and Lecturer at the University of Strathclyde)

12.30-14.00- LUNCH, BUFFET & NETWORKING

CLINICAL APPLICATIONS OF ADVANCED THERAPIES

14.00-14.35- Clinical Applications and Trial Process- Beatriz Duan-Jimerez (Lead R&I Pharmacist, Wythenshaw Hospital, Manchester, UK)

14.35-15.00- Regulatory Framework for cell and gene therapies -Joanne Broadhead (Freeline Therapeutics Ltd)

14.40-15.10-NETWORKING & COFFEE BREAK

15.00-15.45- OPEN QUESTIONS AND DISCUSSION WITH PANEL OF SPEAKERS

16.20-16.30- Summary and Closing Remarks

16.30 Event Closes and Departure

RACHEL KNOTT

Visiting scientist, Robert Gordon University, Aberdeen, Scotland.

ARPAN DESAI
Associate Principal Scientist, Advanced Drug Delivery, Pharmaceutical Science, Research and Developement, Astra Zeneca.

FRANK THIELMANN
Operational Excellence Director for the implementation of process improvement in the manufacturing of a wide portfolio ranging from small molecules to ATMPs, Takeda Pharmaceutical Company.

ZAHRA RATTRAY
Zahra Rattray is a Chancellor’s research fellow and lecturer at the University of Strathclyde Institute of Pharmacy and Biomedical Sciences.

BEATRIZ DUAN-JIMEREZ
Lead R&I Pharmacist. Wythenshawe Hospital, MFT, Manchester,UK

JOANNE BROADHEAD
Freeline Therapeutics Limited
Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts, SG1 2FX, United Kingdom

APS Member Academic £75 +VAT

APS Member Industry   £125 + VAT

Non-member Academic £100 +VAT

Non-member Industry   £150 +VAT

Student (special price)   £50 + VAT

Includes a table top and one free delegate place – (please register the person attending)  £250+VAT

STRATHCLYDE INSTITUTE FOR PHARMACY AND BIOMEDICAL SCIENCES

161 Cathedral St, Glasgow G4 0RE

Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) is a leading centre for research focused on new medicines, better medicines and better use of medicines.